Johnson Pharmacare Limited announced the appointment of Ms. Parul Agrawal as Additional Non-Executive & Independent Director following a board meeting held on February 13, 2026. The appointment was approved in compliance with regulatory requirements and takes effect immediately.

Board Meeting Details

The board meeting was conducted on Friday, February 13, 2026, from 12:15 p.m. to 12:45 p.m. The primary agenda item was the appointment of the new director pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Profile and Qualifications

Ms. Parul Agrawal brings her educational background and professional experience to the board. Her appointment strengthens the company's independent director composition as required under corporate governance norms.

Regulatory Compliance

As part of the appointment process, Ms. Agrawal has submitted the required non-debarment declaration pursuant to SEBI Circular No. LIST/COMP/14/2018-19 dated June 20, 2018. In her declaration, she confirmed that she is not debarred from accessing the capital market and that neither SEBI nor any other authority has passed any order against her that would prevent her from holding the office of director.

The appointment demonstrates Johnson Pharmacare Limited's commitment to maintaining robust corporate governance standards and compliance with regulatory requirements. The company is registered in Gujarat with its office located in Ahmedabad, and the new director's appointment was signed off by Additional Director Umesh Kumar (DIN: 07015921) on behalf of the board.

Johnson Pharmacare Limited announced the appointment of a new Additional Executive Director following a board meeting held on February 09, 2026. The pharmaceutical company's board approved the appointment in compliance with regulatory requirements under SEBI listing obligations.

Board Meeting Details

The board meeting was conducted on Monday, February 09, 2026, with specific timing and agenda focused on directorial appointments.

New Director Appointment

The board approved the appointment of Mr. Umesh Kumar as Additional Executive Director with immediate effect. The appointment was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance

As part of the appointment process, Mr. Umesh Kumar submitted a declaration of non-debarment as required under SEBI regulations. The declaration confirms his eligibility to hold the directorial position and states that he is not related to existing Directors or Key Managerial Personnel of the Company.

Key compliance confirmations include:

• Not debarred from accessing the Capital Market
• No orders passed by SEBI or other authorities debarring him from holding director positions
• Full compliance with SEBI (LODR) 2015 requirements
• Declaration signed on February 09, 2026, from Haryana

Company Information

Johnson Pharmacare Limited operates from its registered office located at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company trades under scrip code 532154 on BSE Limited with ISIN INE560F01022.

The appointment was signed and approved by Rajender Parsad, Additional Director (DIN: 10871533), on behalf of the Board of Directors of Johnson Pharmacare Limited. The company's CIN is L51100GJ1994PLC022388.